A Case-Based Monitoring Approach to Evaluate Safety of COVID-19 Vaccines in a Partially Integrated Health Information System: A Study Protocol

被引:2
作者
Ab Rahman, Norazida [1 ]
Lim, Ming Tsuey [1 ]
Lee, Fei Yee [2 ]
Ong, Su Miin [1 ]
Peariasamy, Kalaiarasu M. [1 ]
Sivasampu, Sheamini [1 ]
机构
[1] Minist Hlth, NIH, Inst Clin Res, Selangor, Malaysia
[2] Minist Hlth, Selayang Hosp, Clin Res Ctr, Selangor, Malaysia
关键词
COVID-19; vaccine safety; adverse events of special interest (AESI); active surveillance; self-controlled; safety surveillance; real world evidence; ACTIVE SURVEILLANCE; DESIGN;
D O I
10.3389/fphar.2022.834940
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In response to Coronavirus disease 2019 (COVID-19) global pandemic, various COVID-19 vaccines were rapidly administered under emergency use authorization. Rare outcomes associated with COVID-19 vaccines might be less likely to be captured in clinical trials, leading to a knowledge gap in real-world vaccine safety. In contrast with high-income countries, many low-to-middle income countries have limited capacity to conduct active surveillance, owing to the absence of large and fully-integrated health information databases. This paper describes the study protocol, which aims to investigate risk of prespecified adverse events of special interests following COVID-19 vaccination in a partially integrated health information system with non-shareable electronic health records. The SAFECOVAC study is a longitudinal, observational retrospective study of active safety surveillance using case-based monitoring approach. This involves linkage of several administrative databases and hospitalization data monitoring to identify adverse events of special interests following administration of COVID-19 vaccines in Malaysia. The source population comprises of all individuals who received at least one dose of COVID-19 vaccine. Self-controlled design and vaccinated case-coverage design will be employed to assess risk of adverse events of special interests and determine the association with vaccine exposure. Data on vaccination records will be obtained from the national COVID-19 vaccination register to identify the vaccination platforms, doses and the timing of vaccinations. The outcome of this study is hospitalization for the adverse events of special interests between March 2021 and June 2022. The outcomes will be obtained through linkage with hospital admission database and national pharmacovigilance database. Findings will provide analysis of real-world data which can inform deliberations by government and public health decision makers relative to the refinement of COVID-19 vaccination recommendations.
引用
收藏
页数:8
相关论文
共 33 条
  • [1] A Vaccine Study Design Selection Framework for the Postlicensure Rapid Immunization Safety Monitoring Program
    Baker, Meghan A.
    Lieu, Tracy A.
    Li, Lingling
    Hua, Wei
    Qiang, Yandong
    Kawai, Alison Tse
    Fireman, Bruce H.
    Martin, David B.
    Nguyen, Michael D.
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2015, 181 (08) : 608 - 618
  • [2] Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
    Barda, Noam
    Dagan, Noa
    Ben-Shlomo, Yatir
    Kepten, Eldad
    Waxman, Jacob
    Ohana, Reut
    Hernan, Miguel A.
    Lipsitch, Marc
    Kohane, Isaac
    Netzer, Doron
    Reis, Ben Y.
    Balicer, Ran D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (12) : 1078 - 1090
  • [3] Optimizing safety surveillance for COVID-19 vaccines
    Chandler, Rebecca E.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2020, 20 (08) : 451 - 452
  • [4] Active surveillance of vaccine safety - A system to detect early signs of adverse events
    Davis, RL
    Kolczak, M
    Lewis, E
    Nordin, J
    Goodman, M
    Shay, DK
    Platt, R
    Black, S
    Shinefield, H
    Chen, RT
    [J]. EPIDEMIOLOGY, 2005, 16 (03) : 336 - 341
  • [5] Suitability of databases in the Asia-Pacific for collaborative monitoring of vaccine safety
    Duszynski, Katherine M.
    Stark, James H.
    Cohet, Catherine
    Huang, Wan-Ting
    Shin, Ju-Young
    Lai, Edward Chia-Cheng
    Man, Kenneth K. C.
    Choi, Nam-Kyong
    Khromava, Alena
    Kimura, Tomomi
    Huang, Kui
    Watcharathanakij, Sawaeng
    Kochhar, Sonali
    Chen, Robert T.
    Pratt, Nicole L.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 (07) : 843 - 857
  • [6] A NEW METHOD FOR ACTIVE SURVEILLANCE OF ADVERSE EVENTS FROM DIPHTHERIA-TETANUS-PERTUSSIS AND MEASLES MUMPS RUBELLA VACCINES
    FARRINGTON, P
    PUGH, S
    COLVILLE, A
    FLOWER, A
    NASH, J
    MORGANCAPNER, P
    RUSH, M
    MILLER, E
    [J]. LANCET, 1995, 345 (8949): : 567 - 569
  • [7] Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support
    Harris, Paul A.
    Taylor, Robert
    Thielke, Robert
    Payne, Jonathon
    Gonzalez, Nathaniel
    Conde, Jose G.
    [J]. JOURNAL OF BIOMEDICAL INFORMATICS, 2009, 42 (02) : 377 - 381
  • [8] A Comparison of Active Adverse Event Surveillance Systems Worldwide
    Huang, Yu-Lin
    Moon, Jinhee
    Segal, Jodi B.
    [J]. DRUG SAFETY, 2014, 37 (08) : 581 - 596
  • [9] International Committee of Medical Journal Editors (ICMJE), 2021, REC COND REP ED PUBL
  • [10] Kawai A., 2020, SAFETY PROTOCOL HOSP